ALS2
Alsin
Also known as: ALS2_HUMAN, ALS2CR6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96Q42
- Gene
- ALS2
- Ensembl
- ENSG00000003393
- Chromosome
- 2
- Canonical length
- 1657 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
OverviewNCBI Gene
The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Canonical amino-acid sequenceUniProt
1657 residues, UniProt reviewed canonical sequence.
>Q96Q42|ALS2
1 MDSKKRSSTE AEGSKERGLV HIWQAGSFPI TPERLPGWGG KTVLQAALGV KHGVLLTEDG
61 EVYSFGTLPW RSGPVEICPS SPILENALVG QYVITVATGS FHSGAVTDNG VAYMWGENSA
121 GQCAVANQQY VPEPNPVSIA DSEASPLLAV RILQLACGEE HTLALSISRE IWAWGTGCQL
181 GLITTAFPVT KPQKVEHLAG RVVLQVACGA FHSLALVQCL PSQDLKPVPE RCNQCSQLLI
241 TMTDKEDHVI ISDSHCCPLG VTLTESQAEN HASTALSPST ETLDRQEEVF ENTLVANDQS
301 VATELNAVSA QITSSDAMSS QQNVMGTTEI SSARNIPSYP DTQAVNEYLR KLSDHSVRED
361 SEHGEKPVPS QPLLEEAIPN LHSPPTTSTS ALNSLVVSCA SAVGVRVAAT YEAGALSLKK
421 VMNFYSTTPC ETGAQAGSSA IGPEGLKDSR EEQVKQESMQ GKKSSSLVDI REEETEGGSR
481 RLSLPGLLSQ VSPRLLRKAA RVKTRTVVLT PTYSGEADAL LPSLRTEVWT WGKGKEGQLG
541 HGDVLPRLQP LCVKCLDGKE VIHLEAGGYH SLALTAKSQV YSWGSNTFGQ LGHSDFPTTV
601 PRLAKISSEN GVWSIAAGRD YSLFLVDTED FQPGLYYSGR QDPTEGDNLP ENHSGSKTPV
661 LLSCSKLGYI SRVTAGKDSY LALVDKNIMG YIASLHELAT TERRFYSKLS DIKSQILRPL
721 LSLENLGTTT TVQLLQEVAS RFSKLCYLIG QHGASLSSFL HGVKEARSLV ILKHSSLFLD
781 SYTEYCTSIT NFLVMGGFQL LAKPAIDFLN KNQELLQDLS EVNDENTQLM EILNTLFFLP
841 IRRLHNYAKV LLKLATCFEV ASPEYQKLQD SSSCYECLAL HLGRKRKEAE YTLGFWKTFP
901 GKMTDSLRKP ERRLLCESSN RALSLQHAGR FSVNWFILFN DALVHAQFST HHVFPLATLW
961 AEPLSEEAGG VNGLKITTPE EQFTLISSTP QEKTKWLRAI SQAVDQALRG MSDLPPYGSG
1021 SSVQRQEPPI SRSAKYTFYK DPRLKDATYD GRWLSGKPHG RGVLKWPDGK MYSGMFRNGL
1081 EDGYGEYRIP NKAMNKEDHY VGHWKEGKMC GQGVYSYASG EVFEGCFQDN MRHGHGLLRS
1141 GKLTSSSPSM FIGQWVMDKK AGYGVFDDIT RGEKYMGMWQ DDVCQGNGVV VTQFGLYYEG
1201 NFHLNKMMGN GVLLSEDDTI YEGEFSDDWT LSGKGTLTMP NGDYIEGYFS GEWGSGIKIT
1261 GTYFKPSLYE SDKDRPKVFR KLGNLAVPAD EKWKAVFDEC WRQLGCEGPG QGEVWKAWDN
1321 IAVALTTSRR QHRDSPEILS RSQTQTLESL EFIPQHVGAF SVEKYDDIRK YLIKACDTPL
1381 HPLGRLVETL VAVYRMTYVG VGANRRLLQE AVKEIKSYLK RIFQLVRFLF PELPEEGSTI
1441 PLSAPLPTER KSFCTGKSDS RSESPEPGYV VTSSGLLLPV LLPRLYPPLF MLYALDNDRE
1501 EDIYWECVLR LNKQPDIALL GFLGVQRKFW PATLSILGES KKVLPTTKDA CFASAVECLQ
1561 QISTTFTPSD KLKVIQQTFE EISQSVLASL HEDFLWSMDD LFPVFLYVVL RARIRNLGSE
1621 VHLIEDLMDP YLQHGEQGIM FTTLKACYYQ IQREKLNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 21 nTPM
- heart muscle: 9.4 nTPM
- liver: 8.3 nTPM
- epididymis: 7.3 nTPM
- skeletal muscle: 7.1 nTPM
- tongue: 5.5 nTPM
Single-cell type
- hematopoietic stem cells: 203 nCPM
- brain excitatory neurons: 167 nCPM
- choroid plexus epithelial cells: 148 nCPM
- mast cells: 146 nCPM
- somatotrophs: 133 nCPM
- cardiomyocytes: 113 nCPM
Immune cell
- basophil: 23 nTPM
- eosinophil: 6.8 nTPM
- NK-cell: 3.1 nTPM
- T-reg: 2.2 nTPM
- MAIT T-cell: 1.9 nTPM
- intermediate monocyte: 1.7 nTPM
Brain region
- cerebellum: 64 nTPM
- choroid plexus: 20 nTPM
- cerebral cortex: 18 nTPM
- basal ganglia: 16 nTPM
- white matter: 15 nTPM
- hippocampal formation: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALS2.
Disease | AllUniProt
Conditions ALS2 is implicated in, by any mechanism.
- Amyotrophic lateral sclerosis 2 (ALS2) MIM:205100
- Juvenile primary lateral sclerosis (JPLS) MIM:606353
- Infantile-onset ascending spastic paralysis (IAHSP) MIM:607225
Disease | GeneticClinVar
119 pathogenic / likely-pathogenic of 1,193 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Infantile-onset ascending hereditary spastic paralysis
- Amyotrophic lateral sclerosis type 2, juvenile
- Juvenile primary lateral sclerosis
- Amyotrophic lateral sclerosis
- Tip-toe gait
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.9
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- behavioral fear response
- endosomal transport
- endosome organization
- intracellular protein localization
- locomotory behavior
- lysosomal transport
- neuromuscular junction development
- neuron projection morphogenesis
- positive regulation of GTPase activity
- positive regulation of protein kinase activity
- positive regulation of Rac protein signal transduction
- protein homooligomerization
- receptor recycling
- regulation of endosome size
- regulation of postsynaptic membrane neurotransmitter receptor levels
- response to oxidative stress
- synaptic transmission, glutamatergic
Molecular functions
- GTPase activator activity
- guanyl-nucleotide exchange factor activity
- identical protein binding
- protein homodimerization activity
- protein serine/threonine kinase activator activity
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dbl homology domain
- Regulator of chromosome condensation, RCC1
- VPS9 domain
- MORN repeat
- Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II
- PH-like domain superfamily
- Dbl homology (DH) domain superfamily
- VPS9 domain superfamily
- Alsin
- Alsin-like, PH-like domain
- Regulator of chromosome condensation (RCC1) repeat
- Vacuolar sorting protein 9 (VPS9) domain
- MORN repeat
- Alsin PH-like domain
- Alsin, helical array domain
- Alsin, DH domain
- Alsin, helical array domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ALS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALS2 as an antibody target. Whether an autoantibody or antibody against ALS2 could matter depends on whether native ALS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...